Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident TexofabBOM:540726 +2.83%64 Current Ratio is 2.11 as of Mar. 2026, which is 57% above its 10-year median of 1.34. GuruFocus rates BOM:540726 with a GF Score™ of 64/100 and a GF Value™ of ₹63.36 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 1,069 Manufacturing - Apparel & Accessories companies, Trident Texofab ranks better than 59.4% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Trident Texofab's current ratio for the quarter that ended in Mar. 2026 was 2.11.
Trident Texofab has a current ratio of 2.11. It generally indicates good short-term financial strength.
The historical rank and industry rank for Trident Texofab's Current Ratio or its related term are showing as below:
BOM:540726'
s Current Ratio Range Over the Past 10 Years
Min: 1.23 Med: 1.34 Max: 2.11
Current: 2.11
During the past 13 years, Trident Texofab's highest Current Ratio was 2.11. The lowest was 1.23. And the median was 1.34.
BOM:540726's Current Ratio is ranked better than 59.4% of 1069
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 1.8
vs BOM:540726: 2.11
Trident Texofab (BOM:540726) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Trident Texofab Current Ratio Related Terms
Trident Texofab Current Ratio Historical Data
* Premium members only.
The historical data trend for Trident Texofab's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Texofab Current Ratio Competitor Comparison
For the Textile Manufacturing subindustry, Trident Texofab's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Texofab Current Ratio vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's Current Ratio distribution charts can be found below:
* The bar in red indicates where Trident Texofab's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Texofab (BOM:540726) has a Current Ratio of 2.11 as of Mar. 2026. This is 57% above median its historical median of 1.34. Over the past decade, Trident Texofab's Current Ratio has ranged from 1.23 to 2.11. According to the industry distribution chart, Trident Texofab ranks #434 out of 1069 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 40.6%.
Is Trident Texofab's Current Ratio too high?
Trident Texofab's current Current Ratio of 2.11 is 57% above median its 10-year median of 1.34. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 2.11. The Manufacturing - Apparel & Accessories industry median Current Ratio is 1.80. Trident Texofab's value of 2.11 is 17.2% above this industry median. Based on the distribution chart, Trident Texofab ranks #434 out of 1069 companies in the Manufacturing - Apparel & Accessories industry, which is above the industry midpoint. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's Current Ratio compare to competitors?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Trident Texofab ranks #434 out of 1069 companies for Current Ratio. This puts Trident Texofab in the upper half of its industry. The industry median Current Ratio is 1.80. Trident Texofab's value of 2.11 is 17.2% above this benchmark. Historically, Trident Texofab's own Current Ratio has ranged from 1.23 to 2.11 over the past decade. While the company's 10-year median is 1.34 vs. the industry median of 1.80, Trident Texofab has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Manufacturing - Apparel & Accessories company?
The median Current Ratio among Manufacturing - Apparel & Accessories companies is 1.80, based on 1,069 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trident Texofab's current Current Ratio of 2.11 is 17.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Manufacturing - Apparel & Accessories industry, the median Current Ratio is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Texofab's current Current Ratio is 2.11, which is 57% above median its own 10-year median of 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.36, compared to a current price of ₹32.33 — trading 49% below its estimated fair value. The current Current Ratio is 2.11, which is 57% above median its 10-year median of 1.34 and 17.2% above the Manufacturing - Apparel & Accessories industry median of 1.80. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current Current Ratio is 2.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Texofab (BOM:540726) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued.
The current stock price of ₹32.33 is trading 49% below its estimated GF Value™ of ₹63.36.
GuruFocus considers Trident Texofab to be Possible Value Trap.
Key valuation signals for BOM:540726:
Current Ratio: 2.11 (57% above median its 10-year median of 1.34)
GF Value™: ₹63.36 vs. price of ₹32.33 (49% below fair value)
Industry Position: 17.2% above the Manufacturing - Apparel & Accessories median (#434 of 1069)
No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score
Get the complete analysis for BOM:540726
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540726 has been successfully added to your 
